Companies /Healthcare

Perrigo Company plc

NYSE: PRGO Drug Manufacturers - Specialty & Generic
$15.06
▲ $0.56 (+3.86%) today
Markets closed · 7:50am ET

24/7 Wall St. View

PRGO at a Glance

Valuation
Market cap
$2.1B
Dividend yield
8.00%
Profitability
Revenue (TTM)
$4.1B
Profit margin
-41.8%
EPS (TTM)
$-12.28
Price
52-week range
$9 – $20
24/7 target
$20.04
Street target
$16.50
Earnings
Next report
Nov 4, 2026

Headquartered in The Sharp Building, Dublin Fiscal year ends December NYSE: PRGO perrigo.com

About Perrigo

Perrigo Company plc (NYSE: PRGO) is a provider of Consumer Self-Care Products and over-the-counter (OTC) health and wellness solutions. The company operates across four segments: Self Care (the largest, encompassing U.S. store-brand OTC products and key European brands), Specialty Care (including Skin Health and Women's Health categories with brands such as Opill, ellaOne, and Mederma), Infant Formula (contract and store brand infant formula, currently under strategic review), and All Other (including Oral Care, also under strategic review). Perrigo serves consumers seeking affordable, quality self-care alternatives and competes across multiple OTC categories in the U.S. and Europe. The company is executing a Three-S strategic plan focused on strengthening its core business, streamlining its portfolio through divestitures (including the completed sale of its Dermacosmetics business), and simplifying operations through its Operational Enhancement Program. Updated

PRGO Coverage

Frequently Asked Questions

What does Perrigo do?

Perrigo Company plc (NYSE: PRGO) is a provider of Consumer Self-Care Products and over-the-counter (OTC) health and wellness solutions.

What is the PRGO stock price target?

24/7 Wall St.'s 12-month price target for PRGO is $20.04, rated Buy. The Wall Street consensus target is $16.50. PRGO price prediction →